281 related articles for article (PubMed ID: 712189)
41. Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
Czaller I; Csuka D; Zotter Z; Veszeli N; Takács E; Imreh É; Varga L; Farkas H
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):175-9. PubMed ID: 27364943
[TBL] [Abstract][Full Text] [Related]
42. Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.
Cicardi M; Igarashi T; Rosen FS; Davis AE
J Clin Invest; 1987 Mar; 79(3):698-702. PubMed ID: 3818946
[TBL] [Abstract][Full Text] [Related]
43. Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema.
Frank MM
Arthritis Rheum; 1979 Nov; 22(11):1295-9. PubMed ID: 508378
[No Abstract] [Full Text] [Related]
44. Hereditary angioedema type II--a study of two families.
Solé D; Leser PG; Naspitz CK
J Investig Allergol Clin Immunol; 1992; 2(6):318-22. PubMed ID: 1342916
[TBL] [Abstract][Full Text] [Related]
45. Antibody to C1-inhibitor in a patient receiving C1-inhibitor infusions for treatment of hereditary angioneurotic edema with systemic lupus erythematosus reacts with a normal allotype of residue 458 of C1-inhibitor.
Donaldson VH; Bissler JJ; Welch TR; Burton MF; Davis AE
J Lab Clin Med; 1996 Oct; 128(4):438-43. PubMed ID: 8833894
[TBL] [Abstract][Full Text] [Related]
46. [Hereditary angioedema. Control and treatment in 7 cases].
Marqués L; Dordal T; Baltasar M; Guspi R; Nogueiras C; Cadahia A
Med Clin (Barc); 1992 Mar; 98(10):378-80. PubMed ID: 1564970
[TBL] [Abstract][Full Text] [Related]
47. Hereditary angioedema controlled with danazol. Report of a case.
Sturdy KA; Beastall RH; Grisius RJ; Oatis GW
Oral Surg Oral Med Oral Pathol; 1979 Nov; 48(5):418-20. PubMed ID: 290943
[TBL] [Abstract][Full Text] [Related]
48. Effect of interferon-gamma on complement gene expression in different cell types.
Lappin DF; Guc D; Hill A; McShane T; Whaley K
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):437-42. PubMed ID: 1531292
[TBL] [Abstract][Full Text] [Related]
49. Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.
Donaldson VH; Wagner CJ; Tsuei B; Kindness G; Bing DH; Harrison RA; Rosen FS
Blood; 1987 Apr; 69(4):1096-101. PubMed ID: 3493816
[TBL] [Abstract][Full Text] [Related]
50. Hereditary angioedema: diagnosis and management.
Chng HH; Boey ML
Singapore Med J; 1990 Apr; 31(2):177-9. PubMed ID: 2371584
[TBL] [Abstract][Full Text] [Related]
51. [Hereditary angioedema. A clinical and immunologic contribution based on our 8 clinical cases under long-term treatment with androgens].
Zimmermann HP; Wüthrich B; Späth P
Schweiz Med Wochenschr; 1983 Jun; 113(24):876-84. PubMed ID: 6879139
[TBL] [Abstract][Full Text] [Related]
52. [Immunocytoma with acquired C1-esterase inhibitor deficiency and recurrent angioneurotic edema].
Kleinhans D; Schach A; Rüther U; Jipp P
Dtsch Med Wochenschr; 1986 May; 111(19):742-4. PubMed ID: 2938925
[TBL] [Abstract][Full Text] [Related]
53. [Angioedema is caused by a defect in C1-inhibitor synthesis].
Jaworska H; Gregorek H; Madaliński K
Przegl Lek; 2000; 57(9):483-8. PubMed ID: 11199871
[TBL] [Abstract][Full Text] [Related]
54. The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.
Hansen CB; Csuka D; Munthe-Fog L; Varga L; Farkas H; Hansen KM; Koch C; Skjødt K; Garred P; Skjoedt MO
J Immunol; 2015 Oct; 195(8):3596-604. PubMed ID: 26371246
[TBL] [Abstract][Full Text] [Related]
55. Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience.
Cicardi M; Bergamaschini L; Cugno M; Hack E; Agostoni G; Agostoni A
J Allergy Clin Immunol; 1991 Apr; 87(4):768-73. PubMed ID: 2013670
[TBL] [Abstract][Full Text] [Related]
56. [Hereditary angioneurotic edema. Treatment of a pseudosurgical digestive attack with C1 inhibitor concentrate].
Laurent J; Intrator L; Branellec A; Sobel A; Rahbar K; Lagrue G
Presse Med; 1987 May; 16(16):762-4. PubMed ID: 2954076
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.
Kramer J; Katz Y; Rosen FS; Davis AE; Strunk RC
J Clin Invest; 1991 May; 87(5):1614-20. PubMed ID: 1902490
[TBL] [Abstract][Full Text] [Related]
58. Guillain-Barré syndrome following danazol and corticosteroid therapy for hereditary angioedema.
Hory B; Blanc D; Boillot A; Panouse-Perrin J
Am J Med; 1985 Jul; 79(1):111-4. PubMed ID: 4014294
[TBL] [Abstract][Full Text] [Related]
59. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
60. Treatment of hereditary angioneurotic oedema (HANE) with tibolone.
Ott HW; Mattle V; Hadziomerovic D; Licht P; Döinghaus K; Rubbert A; Manger K; Manger B; Kalden J; Wildt L
Clin Endocrinol (Oxf); 2007 Feb; 66(2):180-4. PubMed ID: 17223985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
